A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. (Q39425063)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. |
scientific article |
Statements
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma (English)
Vitetta ES
Uhr JW
Jaffe ES
Stone MJ
Sausville EA
Fay JW
Headlee D
Collins RH
Figg WD
Stetler-Stevenson M
Jain V
Solomon D
Lush RM
Senderowicz A